Keywords: fda, panel, says, cox-2s, sold, oks, vioxx

US FDA panel says COX-2s can be sold, OKs Vioxx' return to market?

Article | 28 February 2005

• Print This

A joint panel of the US Food and Drug Administration's Arthritis Advisory and Drug Safety and Risk Management Advisory Committees ...

Enjoying this article? To continue reading you need to login or subscribe.